Archives of Rehabilitation Research and Clinical Translation (Dec 2020)

Complications After Dual Placement of a Baclofen Pump and Ventricular Shunt in Individuals With Severe Brain Injury

  • Elke Pucks-Faes, MD,
  • Judith Dobesberger, MD,
  • Lucas-Michael Halbmayer, MD,
  • Gabriel Hitzenberger, MD,
  • Heinrich Matzak, MD,
  • Leopold Saltuari, MD, MSc

Journal volume & issue
Vol. 2, no. 4
p. 100082

Abstract

Read online

Objective: To assess the complications of dual placement of an intrathecal baclofen (ITB) pump and a ventriculoperitoneal shunt (VPS) in people with severe brain injury. Design: Case series. Setting: Referral center, ambulatory, and hospitalized care. Participants: Referred sample (N=9) composed of 5 men and 4 women with severe brain injuries (5 traumatic brain injuries, 3 subarachnoid hemorrhages, 1 intracerebral hemorrhage) and a mean disease duration of 6±4.5 years (range, 0.5-11.4y). Intervention: Both systems (ie, an ITB device and a VPS system) were implanted in all participants. Main Outcome Measures: We assessed the number and type of complications that occurred after implantation of the second system, as well as subsequent interventions. Results: The ITB delivery system was implanted after the VPS system in 5 patients (ITB group), and the VPS system was the second implanted system in 4 groups (VPS group). Seven complications occurred in 7 patients after implantation of the second system, 4 in the ITB group and 3 in the VPS group. Three of the complications were drug-related, 2 were procedure-related, and 2 were device-related. The complication occurred within 4 days after implantation of the second system in 6 patients. Conclusions: Complications are frequent in patients who undergo implantation of both an ITB delivery device and a VPS system. Drug-related complications were more common. Complications occurred more often when an ITB device was implanted as the second system. The critical period is the first 4 days.

Keywords